Bernhard Küenburg, Laszlo Czollner, Johannes Fröhlich,Ulrich Jordis: Development of a Pilot Scale Process for the Anti-Alzheimer Drug (−)-Galantamine Using Large-Scale Phenolic Oxidative Coupling and Crystallisation-Induced Chiral Conversion. In: Organic Process Research & Development. Band3(6), 1999, S.425–431, doi:10.1021/op990019q.
E. X. Albuquerque, E. F. R. Pereira, Y. Aracava, W. P. Fawcett, M. Oliveira, W. R. Randall, M. Adler: Effective countermeasure against poisoning by organophosphorus insecticides and nerve agents. In: Proceedings of the National Academy of Sciences. 103. Jahrgang, Nr.35, 2006, S.13220–13225, doi:10.1073/pnas.0605370103.
Peter Nordström, Dorota Religa, Anders Wimo, Bengt Winblad, Maria Eriksdotter: The use of cholinesterase inhibitors and the risk of myocardial infarction and death: a nationwide cohort study in subjects with Alzheimer's disease. In: European Heart Journal. Band34, Nr.33, 1. September 2013, S.2585–2591, doi:10.1093/eurheartj/eht182 (oup.com).
Peter Nordström, Dorota Religa, Anders Wimo, Bengt Winblad, Maria Eriksdotter: The use of cholinesterase inhibitors and the risk of myocardial infarction and death: a nationwide cohort study in subjects with Alzheimer's disease. In: European Heart Journal. Band34, Nr.33, 1. September 2013, S.2585–2591, doi:10.1093/eurheartj/eht182 (oup.com).
